FdaApplication
BLA 761306
Identifiers
- fda_app_no: BLA761306
Properties
| Property | Value |
|---|---|
| applicant_name | Eli Lilly and Company |
| application_type | BLA |
| approval_date | 2024-09-13 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| EBGLYSS | LEBRIKIZUMAB-LBKZ | 250MG/2ML | Injection |
| EBGLYSS | — | 250MG/2ML | Injection |
2 products